Abstract. Cardiovascular disease is the leading cause of death in ESRD patients and is strongly associated with malnutrition. The mechanism of malnutrition is not clear, but hypermetabolism is suggested to contribute to cardiac cachexia. This study examined resting energy expenditure (REE) in relation to the clinical outcomes of ESRD patients who receive continuous ambulatory peritoneal dialysis (CAPD) treatment. A prospective observational cohort study was performed in 251 CAPD patients. REE was measured at study baseline using indirect calorimetry together with other clinical, nutritional, and dialysis parameters. Patients were followed up for a mean Ϯ SD duration of 28.7 Ϯ 14.3 mo. REE was 39.1 Ϯ 9.6 and 40.1 Ϯ 9.0 kcal/kg fat-free edema-free body mass per day for men and women, respectively (P ϭ 0.391). Using multiple regression analysis, fat-free edema-free body mass-adjusted REE was negatively associated with residual GFR (P Ͻ 0.001) and serum albumin (P ϭ 0.046) and positively associated with diabetes (P ϭ 0.002), cardiovascular disease (P ϭ 0.009), and C-reactive protein (P ϭ 0.009). At 2 yr, the overall survival was 63.3, 73.6, and 95.9% (P Ͻ 0.0001), and cardiovascular event-free survival was 72.3, 84.6, and 97.2% (P ϭ 0.0003), respectively, for patients in the upper, middle, and lower tertiles of REE. Adjusting for age, gender, diabetes, and cardiovascular disease, patients in the upper and middle tertiles showed a 4.19-fold (95% confidence interval, 2.15 to 8.16; P Ͻ 0.001) and a 2.90-fold (95% confidence interval, 1.49, 5.63; P ϭ 0.002) respective increase in the risk of all-cause mortality compared with those in the lower tertile. However, the significance of REE in predicting mortality was gradually reduced when additional adjustment was made for C-reactive protein, serum albumin, and residual GFR in a stepwise manner. In conclusion, a higher REE is associated with increased mortality and cardiovascular death in CAPD patients and is partly related to its close correlations with residual kidney function, cardiovascular disease, inflammation, and malnutrition in these patients.
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Malnutrition is usually the consequence of energy imbalance and can be attributed to changes in dietary intake or energy expenditure or both. Sustained hypermetabolism can lead to energy imbalance and wasting if not compensated for by an increase in energy intake. Indeed, hypermetabolism was suggested to be one of the contributory factors for cachexia in disease states such as cardiac failure (1) , chronic obstructive pulmonary disease (2) , and malignancy (3, 4) . However, its association with protein-energy malnutrition in ESRD patients has not been established. Protein-energy malnutrition is a significant complication and predicts mortality in ESRD patients (5, 6) . However, malnutrition is well known to be associated with inflammation and atherosclerotic vascular disease in ESRD patients (7, 8) . Whereas the severity of inflammation as denoted by the acute-phase response or proinflammatory cytokine is related to resting hypermetabolism in diseases such as AIDS (9) , chronic obstructive pulmonary disease (10) , and malignancy (4), it is not known whether a higher resting energy expenditure (REE) is also a marker of inflammation or malnutrition in ESRD patients, in whom high prevalence of these complications is observed.
Studies that examined REE in patients with ESRD showed conflicting data. Ikizler et al. (11) reported resting hypermetabolism in chronic hemodialysis patients that was noted to increase further during hemodialysis procedure. Recent study showed higher REE in patients who receive dialysis, regardless of the modality, than chronic renal failure patients who did not yet require dialysis (12) . Conversely, other studies showed that REE of chronic renal failure patients were either reduced (13) or no different from normal control subjects (14, 15) . In this prospective follow-up study, we evaluated factors associated with REE in a large cohort of ESRD patients who were receiving continuous ambulatory peritoneal dialysis (CAPD) therapy and determined whether a single measurement of REE is related to the clinical outcomes of these peritoneal dialysis (PD) patients.
Materials and Methods

Study Population
This study was approved by the Human Research Ethics Committee of the Chinese University of Hong Kong. Altogether, 251 patients who were receiving CAPD treatment for Ն3 mo were recruited from the Prince of Wales Hospital in Hong Kong and represented 90% of the total PD patient pool in our hospital. The remaining 10% of patients were excluded because of underlying malignancy; systemic inflammatory disease such as systemic lupus erythematosus, active infections, chronic liver disease, or chronic obstructive airway disease; or because they received PD treatment for Ͻ3 mo. Informed consent was obtained from all patients. At the time of study entry, clinical and demographic information including time on dialysis before enrollment into the study, smoking habits, underlying cause of renal failure, history of diabetes, and cardiovascular disease were recorded. Cardiovascular disease was defined as the presence of angina; previous myocardial infarction with or without angiographically confirmed coronary artery disease; history of coronary artery bypass surgery or stenting procedure; or history of congestive heart failure, cerebrovascular, disease, or peripheral vascular disease. Dry weight was measured to the nearest 0.1 kg by a weighing scale, with patients' abdomen drained dry of peritoneal fluid. Body height was measured to the nearest 0.5 cm. Body mass index was calculated as weight in kilograms divided by height in meters squared.
Measurement of REE
REE was measured by indirect calorimetry using DeltatracII, MBM-200, Metabolic monitor (Datex, Helsinki, Finland) at study baseline. It was conducted under standardized conditions in the morning in all patients. Patients fasted overnight for at least 10 h, and all medications were omitted on the morning before undergoing indirect calorimetry. Patients were asked to avoid all strenuous exercise for at least 12 h before the measurement of REE. On arrival, patients were asked to lie down for a mandatory 15-min rest period. REE was then measured for~30 min with patients lying supine at complete physical rest, alone and undisturbed in a quiet room. The REE was determined from the rate of oxygen consumption and carbon dioxide production. Readings from the first 5 min were discarded. An average was taken from the subsequent readings of 25 min of steady state and was used for the calculation of REE. The within-subject coefficient of variation of the REE measurement was 5.1%. REE was adjusted per kilogram of fat-free edema-free body mass or lean body mass (16) .
Assessment of Nutrition Status and Degree of Inflammation
Fat-free, edema-free body mass or lean body mass was calculated using creatinine kinetics. Total daily creatinine production was measured as the sum of daily creatinine excreted in the dialysate and urine plus the estimated daily creatinine lost in the gut (17) . Fat-free edema-free body mass was then computed according to the following equation (18, 19) : fat-free, edema-free body mass (kg) ϭ 0.029*total creatinine production in mg/d ϩ 7.38.
Subjective global assessment (SGA) was used to evaluate the overall protein-energy nutritional status (20, 21) and was performed by a single experienced research assistant who was blinded to other details of patients. It includes assessing the patient's history of weight loss, presence of anorexia and vomiting, and grading of muscle wasting and loss of subcutaneous fat. Edema is not used in grading of SGA, but its presence or absence has to be taken into account when assessing changes in body weight. On the basis of these assessments, each patient was graded a score that reflected the nutrition status: 1 ϭ normal nutrition, 2 ϭ mild malnutrition, 3 ϭ moderate malnutrition, and 4 ϭ severe malnutrition (21) . Serum albumin and C-reactive protein (CRP) were measured at the time of assessing REE and SGA. Serum albumin was measured by the bromcresol purple method. CRP was measured using the Tina-quant CRP (Latex) ultrasensitive assay (Roche Diagnostics GmbH, Mannheim, Germany).
Assessment of Indices of Dialysis Adequacy
Patients were asked to bring back 24-h urine and dialysate on the same day of assessing REE and SGA for measurement of urea and creatinine production. Total weekly urea and creatinine clearance were then calculated using standard methods (22) . Contribution of urea clearance by PD was estimated separately. Residual GFR was calculated as the average of 24-h urine urea and creatinine clearance (23) . Creatinine concentration in dialysate was corrected for interference by glucose according to a reference formula determined in our laboratory (24) . Total body water was derived using Watson formula (25) . Protein equivalent nitrogen appearance (PNA) was calculated by the method described by Randerson et al. (26) .
Study Outcome
Patients were followed up prospectively to an end point of death, kidney transplant, or permanent transfer to hemodialysis after baseline assessment of REE. No patients were lost to follow-up. Patients who underwent kidney transplantation or switched to permanent hemodialysis were censored at the time of transfer to alternative renal replacement therapy. All deaths were recorded accurately with the exact cause of death provided by the attending physician, who had no knowledge of the REE results. In the case of death out of hospital, family members were interviewed by telephone to ascertain the circumstances surrounding death. The primary end point was death from all causes, which is an objective, clinically relevant, and unbiased end point (27) . Death from cardiovascular causes included death associated with a definite myocardial ischemic event, heart failure, arrhythmia, peripheral vascular accident, and cerebrovascular accident, all of which were defined according to standard clinical criteria, and sudden death, which was defined as unexpected natural death within 1 h from the symptom onset and without any previous condition that would seem to be fatal (28, 29) .
Statistical Analyses
Continuous variables were tested for normal distribution with the Kolmogorov-Smirnov test before further statistical analysis. The associations of fat-free edema-free body mass-adjusted REE with the different clinical and biochemical parameters were tested by the Spearman rank correlation analysis and multiple linear regression analysis. The study cohort was stratified into tertiles according to the fat-free edema-free-adjusted REE. The significance of differences among tertiles was tested by the one-way ANOVA or Kruskal-Wallis or 2 test where appropriate. Post hoc analysis was performed by the Bonferroni method. Characteristics of patients who remained alive and those who died were compared by the unpaired t test, MannWhitney test, or 2 test where appropriate. Survival curves of the three tertiles were generated according to the Kaplan-Meier method and compared by the Mantel log-rank test. Factors with P Ͻ 0.25 on univariate analysis for all-cause and cardiovascular mortality were further considered in the multivariable Cox regression analysis. The all-cause and cardiovascular mortality of patients in the upper and middle tertiles compared with that of the lower tertile (reference group) were first tested controlling for covariates with P Ͻ 0.25 on univariate analysis (not including inflammation, malnutrition, and residual GFR; basic model). To examine whether inflammation, malnutrition, and residual renal function further modify the relationships between REE and all-cause and cardiovascular mortality, we made additional adjustments for inflammatory marker, CRP, nutritional parameter, serum albumin, and residual GFR in a stepwise manner in multivariable Cox regression models. Statistical analysis was performed using SPSS software, version 10.0 (SPSS, Inc., Chicago, IL). P Ͻ 0.05 was considered statistically significant.
Results
The baseline characteristics of study patients are presented in Table 1 . The mean Ϯ SD REE was 39.1 Ϯ 9.6 and 40.1 Ϯ 9.0 kcal/kg fat-free edema-free body mass per day for men and women, respectively (P ϭ 0.391). Using Spearman rank correlation analysis, fat-free edema-free body mass-adjusted REE was negatively correlated with serum albumin (r ϭ Ϫ0.281, PϽ 0.001) and residual GFR (r ϭ Ϫ0.488, P Ͻ 0.001) but positively correlated with CRP (r ϭ 0.266, P Ͻ 0.001). Patients were stratified into tertiles according to the fat-free edema-free body mass-adjusted REE, namely those with REE Ͻ34.3 kcal/kg fat-free edema-free body mass per day (lower tertile), those between 34.3 and 42.4 kcal/kg fat-free edemafree body mass per day (middle tertile), and those Ն42.4 kcal/kg fat-free edema-free body mass per day (upper tertile). Characteristics of study participants stratified in tertiles of REE are shown in Table 1 . Using multiple linear regression analy- sis,residual GFR, diabetes, cardiovascular disease, serum albumin, and CRP were independent factors associated with fatfree edema-free body mass-adjusted REE ( Table 2 ). Our study cohort was followed for a mean duration of 28.7 (SD, 14.3) months after baseline assessment of REE. During the follow-up period, 47 men and 40 women died. Twentyeight (11.2%) patients were transferred to long-term hemodialysis, and 31 (12.4%) patients underwent kidney transplantation. Excluding patients who underwent kidney transplantation and those who were permanently transferred to hemodialysis (n ϭ 59), we compared the baseline characteristics of patients who survived (n ϭ 105) versus those who died (n ϭ 87) during follow-up (Table 3 ). The nonsurvivors were older (P Ͻ 0.001), were dialyzed for longer (P ϭ 0.051), had greater prevalence of diabetes (P ϭ 0.030) and cardiovascular disease (P ϭ 0.001), had lower total weekly urea (P ϭ 0.015) and creatinine clearance (P ϭ 0.017), and had lower residual GFR (P ϭ 0.003). The nonsurvivors were more malnourished according to a number of nutrition indices, including SGA (P ϭ 0.002), fat-free edema-free body mass (P ϭ 0.002), and serum albumin (P Ͻ 0.001). They also showed more inflammation as denoted by higher CRP (P Ͻ 0.001) and had higher fat-free edema-free body mass-adjusted REE (P Ͻ 0.001) than the survivors.
Causes of death of our study cohort are shown in Table 4 . Cardiovascular causes accounted for 63% of all deaths, followed by peritonitis in 14%, other infections or sepsis in 14%, and other miscellaneous causes in 9%. Six patients died outside the hospital, and all of them had sudden cardiac death. The overall mortality during the follow-up period was 47.6 and 42.2%, respectively, for patients in the upper and middle tertiles compared with 14.3% for the lower tertile (P Ͻ 0.001). Death from cardiovascular causes was 33.3% for patients in the upper tertile compared with 20.5 and 11.9% for patients in the middle and lower tertiles, respectively (P Ͻ 0.001). The overall survival and cardiovascular event-free survival of patients in the three tertiles are illustrated in the Kaplan-Meier curves in Figure 1 . At 2 yr, the overall survival was 63.3, 73.6, and 95.9% for patients in the upper, middle, and lower tertiles, respectively (P Ͻ 0.0001). Cardiovascular event-free survival was 72.3, 84.6, and 97.2% for patients in the upper, middle, and lower tertiles, respectively (P ϭ 0.0003).
Univariate analysis results for all-cause and cardiovascular mortality in CAPD patients are detailed in Tables 5 and 6 . Adjusting for covariates including age, male gender, diabetes, and cardiovascular disease (basic model, increased risk of all-cause mortality than those in the lower tertile, respectively. However, the significance of REE in predicting all-cause mortality was gradually reduced when additional adjustments were made for inflammatory marker CRP, nutritional marker serum albumin. and residual GFR in a stepwise manner in the multivariable Cox regression models (models 1 to 3, Table 5 ). Table 6 shows the risk of cardiovascular mortality in relation to the REE. Adjusting for age, diabetes, and cardiovascular disease, patients in the upper tertile of REE had a 3.01-fold (95% CI, 1.43 to 6.35) higher risk of cardiovascular mortality than those in the lower tertile (basic model, Table 6 ). However, the significance of REE was gradually lost in a stepwise manner when additionally adjusting for CRP, serum albumin, and residual GFR in multivariable Cox regression models (models 1 to 3, Table 6 ).
Discussion
The effects of energy metabolism on the clinical outcomes were previously explored in different disease states, but results so far remained inconclusive. Whereas some studies suggested that hypermetabolism was associated with decreased survival in cancer patients (3), others observed longer survival in hypermetabolic patients (30) . In this prospective study, we provide important evidence that a higher REE is associated with greater mortality and cardiovascular death in ESRD patients on CAPD. This extends further the observations from a previous study showing that an elevated REE is predictive of future mortality in apparently healthy humans (31) . Although the exact mechanism for the association between REE and mortality remains to be elucidated, our current study provides important evidence that loss of residual renal function, cardiovascular disease, inflammation, and malnutrition, all wellknown predictors for mortality, show significant and independent associations with higher REE, indicating that loss of residual kidney function, cardiovascular disease, malnutrition, Multiple R ϭ 0.573, P Ͻ 0.001. Out of the model with age (P ϭ 0.260), gender (P ϭ 0.247), duration of dialysis (P ϭ 0.484), hemoglobin (P ϭ 0.839), systolic blood pressure (P ϭ 0.939), and diastolic blood pressure (P ϭ 0.112).
and inflammation might have an important contribution to the association between REE and mortality in dialysis patients.
Previous studies showed that REE is increased in patients with heart failure (1, 32) and that the clinical severity of heart failure as reflected by the New York Heart Association classification corresponds to the magnitude of increase in resting energy demand (33) . This well accords with our study showing also an independent positive association between cardiovascular disease and higher REE. The higher systolic and pulse pressure across the three tertiles of increasing REE are additional evidence to indicate an elevated REE in patients with underlying cardiovascular abnormality. The exact mechanism for this association is not clear, but increased myocardial oxygen consumption and increased metabolic cost of breathing have been suggested as contributing factors to resting hypermetabolism in patients with cardiovascular disease (1, 34) . Increased circulating tumor necrosis factor are noted in cachectic heart failure patients (35) , but their relation to alteration in energy metabolism remains speculative. Inflammation is a powerful predictor of mortality in ESRD patients who are on maintenance dialysis (36, 37) . A previous study also showed an important link among cardiovascular disease, inflammation, and malnutrition in ESRD patients (7) . In this study, the presence of higher REE is matched by a greater degree of inflammatory activity and well accords with studies showing an important association between resting hypermetabolism and chronic immune activation in diseases such as chronic obstructive pulmonary disease (10) and malignancy (4, 38) . Although the exact dynamic relationships between inflammation and resting hypermetabolism remains poorly understood, studies in both animals (39, 40) and humans (41, 42) indicated that excessive production of proinflammatory cytokines was linked to hypermetabolism and loss of body cell mass.
REE accounts for 60 to 80% of the total energy expenditure. Hence, its increase contributes significantly to the development of cachexia and is indeed observed in patients with heart failure (1, 32) and in the elderly (43) . In this study, patients with higher REE were not only more inflamed but also clinically more malnourished according to a number of different nutrition indices. Furthermore, the association between REE and mortality was partly reduced after adjusting for nutrition indices and inflammatory marker, suggesting that the association between REE and mortality may in part be related to malnutrition and inflammation. Taken together, our results suggest that a higher REE should be considered as an important component of the malnutrition-inflammation syndrome that frequently ac- companies ESRD patients with underlying cardiovascular disease.
One key and novel finding of this study is the significant negative association between REE and residual renal function in patients who are on CAPD. The kidneys, in healthy individuals, may account for up to 20% of REE. Hence, functional alteration of the kidney may lead to disturbance in energy metabolism. However, the status of energy expenditure in renal failure has remained controversial. Whereas some experimental studies suggested that both acute and chronic renal failure was associated with hypometabolism (44, 45) , another study noted either hypermetabolism in patients with acute renal failure (46) or energy metabolism that was no different from normal (14, 15) . Two other recent studies that examined the resting metabolic rate in relation to renal function have also yielded conflicting data. One study suggested a decrease in REE with decline in renal function and was assumed to occur as a result of decreased oxygen consumption of the kidneys (47) , whereas the other study showed normal REE with deteriorating excretory function of the kidneys, suggesting an increase in energy expenditure per body cell mass (48) . Our current study indicates that despite loss of excretory function, the kidneys in ESRD patients may retain important metabolic functions as evidenced by the strong and negative correlation between the degree of residual renal function and REE. Furthermore, the significance of REE in predicting all-cause mortality was substantially reduced and its significance in predicting cardiovascular mortality was virtually lost after also adjusting for residual renal function. This suggests that the association between higher REE and higher mortality in CAPD patients is indeed partly related to the loss of residual renal function. A previous study demonstrated higher REE in hemodialysis patients, and the REE increased further during the hemodialysis procedure (11) . In this study, no significant difference was observed in the PD clearance across the three tertiles of increasing REE, giving evidence that the loss in residual renal function but not changes in the dialysis clearance contributes to the increased REE of our patients. Study has also showed no effect of intra-abdominal fluid on the REE (49) .
Residual renal function has been shown to contribute significantly to the overall nutrition status of PD patients (50) . However, recent study also observed an increased inflammatory activity with a decline in residual renal function (51, 52) . Together with the current observation of higher REE among patients with lower residual renal function, this suggests that a greater REE and inflammation are associated phenomena and parallel the decline in residual renal function. The greater resting metabolic state and associated inflammation might also contribute to a greater degree of malnutrition observed in anuric patients. Generally speaking, a greater lean body mass should be associated with a higher REE. However, in this study, we observed an inverse relationship between lean body mass and REE. In other words, patients with greater REE had lower lean body mass. This suggests that some lean body mass loss may develop in response to the higher REE, greater inflammation, or loss of residual renal function as supported by the positive correlations between REE and CRP and its negative correlations with serum albumin and residual renal function. We also studied whether the association between REE and lean body mass was influenced by the vintage of dialysis by testing for the lean body mass ϫ vintage interaction term. Lean body mass showed no significant interaction with vintage of dialysis in relation to the REE (P ϭ 0.817). This indicates that the association between lean body mass and REE was not related to dialysis vintage. It is important to caution that the associations observed with REE are cross-sectional. Serial measurements of REE with changes in lean body mass will be needed to evaluate a possible causal link between REE and lean body mass. Higher REE was observed in diabetic PD patients. This is in keeping with previous studies showing that patients with poorly controlled diabetes have enhanced REE (53, 54) and that the REE is reduced after glucose control is improved (55) . Insulin deficiency or hyperglucagonemia is suggested as the underlying mechanism that promotes an increase in REE by increasing the rate of gluconeogenesis, a high energy-consuming process (56, 57) . Some limitations of this study are noteworthy. In this study, to 74.7 kcal/kg fat-free edema-free body mass per day. Log-rank test showed significant difference in overall survival between lower and middle tertiles (P ϭ 0.0001) and between lower and upper tertiles (P Ͻ 0.0001) but not between middle and upper tertiles (P ϭ 0.1692). Cardiovascular event-free survival showed significant difference between lower and upper tertiles (P ϭ 0.0001) and between middle and upper tertiles (P ϭ 0.0264) but not between lower and middle tertiles (P ϭ 0.0791). prevalent but not incident patients were included and may introduce survival bias. Moreover, a single measurement of REE was done at study baseline and may not reflect changes over long periods. Serial evaluations of REE with changes observed in sequence with changes in CRP and albumin may be more useful in establishing the association more strongly and may even generate new, important hypotheses. Furthermore, only patients who were on PD treatment were studied as it accounts Ͼ75% of the dialysis population in Hong Kong. Whether our results are also applicable to hemodialysis or predialysis chronic renal failure patients requires further investigation.
Our results have several potentially important implications. First, the finding that a higher REE shows important associations with residual renal function, inflammation, malnutrition, and cardiovascular disease and contributes to greater mortality and cardiovascular death in CAPD patients may expand its clinical usefulness. Regular monitoring of REE may be useful in identifying patients who are at increased risk for mortality and morbidity for earlier active intervention. Second, given that loss of residual renal function, cardiovascular disease, inflammation, and malnutrition all are important associates of a greater resting metabolic state, it raises an important question as to whether early identification of PD patients with higher REE for additional energy supplementation may prevent malnutrition and possibly reduce morbidity and mortality in this population. Further study is needed to elucidate the exact mechanistic links between loss of residual renal function, cardiovascular disease, inflammation, and malnutrition and greater REE in PD patients. 
